Showing results (61-70 of 370) with videos related to
Sort By:
Pageof 37
International Journal of Public Health|June 1, 2022
COVID-19 Impacts Across Multiple Life Domains of Vulnerable Socio-Demographic Groups Including Migrants: A Descriptive Cross-Sectional StudyFelix P Chilunga, Liza Coyer, Didier Collard, et al.Vaccine|August 19, 2014
Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness studyBethany White, Annie Madden, Maria Prins, et al.Addiction (Abingdon, England)|January 26, 2013
Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?Anneke S de Vos, Jannie J van der Helm, Amy Matser, et al.Drug and Alcohol Review|November 2, 2012
Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugsBethany White, Annie Madden, Margaret Hellard, et al.Harm Reduction Journal|January 7, 2021
Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspectiveDaniela K van Santen, Roel A Coutinho, Anneke van den Hoek, et al.AIDS (London, England)|January 10, 2014
Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort studyAnneke S de Vos, Maria Prins, Roel A Coutinho, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2011
No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversionBart Grady, Charlotte van den Berg, Jannie van der Helm, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|July 18, 2025
Extrapulmonary tuberculosis in The Netherlands, an epidemiologic overview, 1993-2022Frouke A Procee, Jizzo R Bosdriesz, Frank G J Cobelens, et al.Plos One|October 8, 2024
Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS studyRenee Bolijn, Annemieke M W Spijkerman, Henrike Galenkamp, et al.The International Journal on Drug Policy|June 14, 2017
HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015Daniëla K van Santen, Jannie J van der Helm, Karen Lindenburg, et al.Pageof 37